1 |
32964767 |
10.1080/10428194.2020.1821011 |
2021 |
Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas. |
TAP1 |
2 |
35845006 |
10.1002/jha2.116 |
2020 |
Genetic aberrations of <i>NLRC5</i> are associated with downregulated MHC-I antigen presentation and impaired T-cell immunity in follicular lymphoma. |
TAP1 |
3 |
29107940 |
10.1038/nature24627 |
2017 |
Structure of the human MHC-I peptide-loading complex. |
TAP1 |
4 |
26910071 |
10.1007/978-1-4939-3347-1_7 |
2016 |
Fluorimetric Methods for Analysis of Permeability, Drug Transport Kinetics, and Inhibition of the ABCB1 Membrane Transporter. |
TAP1 |
5 |
23302045 |
10.3109/10428194.2013.764417 |
2013 |
Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis. |
TAP1 |
6 |
22419807 |
10.1128/JVI.07216-11 |
2012 |
Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA. |
TAP1 |
7 |
20020123 |
10.1007/s00262-009-0805-5 |
2010 |
Effective adoptive therapy of tap-deficient lymphoma using diverse high avidity alloreactive T cells. |
TAP1 |
8 |
17285277 |
10.1007/s00277-007-0256-z |
2007 |
Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation. |
TAP1 |
9 |
16585582 |
10.4049/jimmunol.176.8.4869 |
2006 |
Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. |
TAP1 |
10 |
15905524 |
10.4049/jimmunol.174.11.6829 |
2005 |
Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection. |
TAP1 |
11 |
16103103 |
10.1158/0008-5472.CAN-03-3734 |
2005 |
Identification of mechanisms underlying transporter associated with antigen processing deficiency in metastatic murine carcinomas. |
TAP1 |
12 |
15265880 |
10.4049/jimmunol.173.3.1526 |
2004 |
Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells. |
TAP1 |
13 |
14558951 |
|
2003 |
[Expression of transporter associated with antigen processing (TAP) in childhood acute leukemia and its clinical significance]. |
TAP1 |
14 |
11781255 |
10.1182/blood.v99.2.690 |
2002 |
HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. |
TAP1 |
15 |
11169961 |
10.1002/1097-0215(200002)9999:9999<::aid-ijc1056>3.0.co;2-k |
2001 |
Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence. |
TAP1 |
16 |
11340574 |
10.1002/1097-0215(20010601)92:5<692::aid-ijc1237>3.0.co;2-z |
2001 |
Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism. |
TAP1 |
17 |
10760797 |
10.1002/(SICI)1521-4141(200004)30:4<1088::AID-IMMU1088>3.0.CO;2-O |
2000 |
Innate and adaptive immunity to tumors: IL-12 is required for optimal responses. |
TAP1 |
18 |
10597194 |
10.1002/(sici)1097-0215(19991210)83:6<772::aid-ijc13>3.0.co;2-g |
1999 |
CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines. |
TAP1 |
19 |
9443401 |
|
1998 |
Mouse models for hereditary nonpolyposis colorectal cancer. |
TAP1 |
20 |
9443410 |
|
1998 |
Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells. |
TAP1 |
21 |
9531330 |
10.1046/j.1365-2141.1998.00631.x |
1998 |
Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course. |
TAP1 |
22 |
9551890 |
|
1998 |
Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice. |
TAP1 |
23 |
9562372 |
10.1016/s0165-2478(97)00157-0 |
1998 |
Peptide transport in human lymphoblastoid and tumor cells: effect of transporter associated with antigen presentation (TAP) polymorphism. |
TAP1 |
24 |
9680372 |
|
1998 |
Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition. |
TAP1 |
25 |
9725200 |
|
1998 |
Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1. |
TAP1 |
26 |
9746788 |
|
1998 |
Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease. |
TAP1 |
27 |
9764810 |
10.1097/00008390-199808000-00008 |
1998 |
TAP prefers to transport melanoma antigenic peptides which are longer than the optimal T-cell epitope: evidence for further processing in the endoplasmic reticulum. |
TAP1 |
28 |
9129970 |
10.1016/S0198-8859(97)00001-3 |
1997 |
Localization of class I histocompatibility molecule assembly by subfractionation of the early secretory pathway. |
TAP1 |
29 |
9278330 |
|
1997 |
Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination. |
TAP1 |
30 |
9317117 |
|
1997 |
Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10. |
TAP1 |
31 |
9550373 |
|
1997 |
Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells. |
TAP1 |
32 |
8764046 |
10.1128/JVI.70.8.5357-5362.1996 |
1996 |
Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. |
TAP1 |
33 |
8765034 |
10.1002/eji.1830260831 |
1996 |
Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. |
TAP1 |
34 |
8900437 |
10.1002/(SICI)1097-0215(19961009)68:2<251::AID-IJC19>3.0.CO;2-D |
1996 |
Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells. |
TAP1 |
35 |
7565411 |
10.1128/mr.59.3.387-405.1995 |
1995 |
Immune regulation in Epstein-Barr virus-associated diseases. |
TAP1 |
36 |
7774641 |
10.1002/eji.1830250536 |
1995 |
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. |
TAP1 |
37 |
7517178 |
10.1093/intimm/6.4.639 |
1994 |
Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line. |
TAP1 |
38 |
7796675 |
10.1002/9780470514672.ch2 |
1994 |
Potential antigenic targets on Epstein-Barr virus-associated tumours and the host response. |
TAP1 |
39 |
7972022 |
10.1073/pnas.91.23.11128 |
1994 |
Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse. |
TAP1 |